Aurora Cannabis (ACB) Current Deferred Revenue (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Current Deferred Revenue of $1.4 million for Q4 2025, down 38.96% year-over-year from $2.2 million in Q4 2024, and up 31.26% quarter-over-quarter from $1.0 million in Q3 2025.
Aurora Cannabis (ACB) Current Deferred Revenue (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Current Deferred Revenue for 8 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Deferred Revenue fell 38.96% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (down 38.96% YoY), while the FY2025 annual figure was $772590.5, down 38.29% from the prior year.
- Current Deferred Revenue improved to $1.4 million in Q4 2025 per ACB's latest filing, from $1.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $5.2 million in Q3 2021 and bottomed at $748488.3 in Q1 2025.
- Historically, Current Deferred Revenue has averaged $2.2 million across 5 years, with a median of $1.8 million in 2022.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue soared 221.14% — and 2023, when it slumped 67.08%.
- Aurora Cannabis' Current Deferred Revenue stood at $4.4 million in 2021, then tumbled by 53.57% to $2.0 million in 2022, then grew by 26.45% to $2.6 million in 2023, then decreased by 12.39% to $2.2 million in 2024, then plunged by 38.96% to $1.4 million in 2025.
- Business Quant data shows ACB's Current Deferred Revenue at $1.4 million in Q4 2025, $1.0 million in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 748,488.30 |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 3.05 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Sep 30, 2021 | 5.23 Mn |
| Jun 30, 2021 | 3.39 Mn |
| Mar 31, 2021 | 3.23 Mn |